Jay Barth, MD, has been named chief medical officer of Ascidian Therapeutics, a biotech drug development company.
Dr. Barth has more than 25 years of experience in drug development and most recently served as chief medical officer for Lexeo Therapeutics, a gene therapy company, according to a March 20 news release from Ascidian.
In his new role, Dr. Barth will lead clinical development across the company’s ophthalmology, neurological, neuromuscular and genetically defined diseases pipelines.
Here are three physicians recently appointed to leadership positions, as reported by Becker’s: 1. Geraldine Ong, MD, a cardiologist and…
Geraldine Ong, MD, a cardiologist and clinical investigator, has been appointed medical director of NYU Langone Health’s Aortic Center in…
Karen Pinsky, MD, has been appointed CEO of Penn Medicine Chester County Hospital in West Chester, Pa. According to an…
Comments are closed.